125 related articles for article (PubMed ID: 2611615)
1. Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study.
Fosså SD; Raabe N; Moe B
Br J Urol; 1989 Nov; 64(5):468-71. PubMed ID: 2611615
[TBL] [Abstract][Full Text] [Related]
2. Is interferon with or without vinblastine the "treatment of choice" in metastatic renal cell carcinoma? The Norwegian Radium Hospital's experience 1983-1986.
Fosså SD
Semin Surg Oncol; 1988; 4(3):178-83. PubMed ID: 3055161
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine].
Bergerat JP; Dufour P; Soyer Y; Bollack C; Jacqmin D; Prevot G; Juraschek F; Bailly G; de Garis S; Lang JM
Presse Med; 1987 Nov; 16(39):1953-6. PubMed ID: 2962158
[TBL] [Abstract][Full Text] [Related]
4. Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
Fosså SD; Gunderson R; Moe B
Cancer; 1990 Jun; 65(11):2451-4. PubMed ID: 2337859
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha 2a and vinblastine in advanced renal cell cancer: a clinical phase I-II study.
Kellokumpu-Lehtinen P; Nordman E
J Biol Response Mod; 1990 Aug; 9(4):439-44. PubMed ID: 2395008
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma.
Fosså SD; de Garis ST; Heier MS; Flokkmann A; Lien HH; Salveson A; Moe B
Cancer; 1986 Apr; 57(8 Suppl):1700-4. PubMed ID: 3948141
[TBL] [Abstract][Full Text] [Related]
8. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses.
Cetto GL; Franceschi T; Turrina G; Chiarion-Sileni V; Capelli MC; Bellini A; Paccagnella A; Bassetto MA; Molino AM; de Sandre G
Semin Surg Oncol; 1988; 4(3):184-90. PubMed ID: 3055162
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell cancer treated with recombinant alpha 2a interferon and vinblastine.
Massidda B; Migliari R; Padovani A; Scarpa RM; Pellegrini P; Cortesi E; Usai E; Pellegrini A
J Chemother; 1991 Dec; 3(6):387-9. PubMed ID: 1819623
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.
Porzsolt F; Messerer D; Hautmann R; Gottwald A; Sparwasser H; Stockamp K; Aulitzky W; Moormann JG; Schumacher K; Rasche H
J Cancer Res Clin Oncol; 1988; 114(1):95-100. PubMed ID: 2965154
[TBL] [Abstract][Full Text] [Related]
12. Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma.
Sertoli MR; Brunetti I; Ardizzoni A; Falcone A; Guarneri D; Boccardo F; Martorana G; Curotto A; Sicignano A; Rosso R
Am J Clin Oncol; 1989 Feb; 12(1):43-5. PubMed ID: 2492141
[TBL] [Abstract][Full Text] [Related]
13. Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
Bergerat JP; Herbrecht R; Dufour P; Jacqmin D; Bollack C; Prevot G; Bailly G; de Garis S; Juraschek F; Oberling F
Cancer; 1988 Dec; 62(11):2320-4. PubMed ID: 3141036
[TBL] [Abstract][Full Text] [Related]
14. Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: a progress report.
Fosså SD; De Garis ST
Int J Cancer Suppl; 1987; 1():36-40. PubMed ID: 3476476
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
Otto U; Schneider A; Denkhaus H; Conrad S
Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
[TBL] [Abstract][Full Text] [Related]
16. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinoma.
Schornagel JH; Verweij J; ten Bokkel Huinink WW; Klijn JG; de Mulder PH; Debruyne FM; van Deijk WA; Roozendaal K; Kok TC; Veenhof KH
J Urol; 1989 Aug; 142(2 Pt 1):253-6. PubMed ID: 2746739
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant therapy with vinblastine and interferon in metastatic renal carcinoma].
Cocimano V; Marino G; Brigato R; Cevoli R; Griffa D
Minerva Urol Nefrol; 1989; 41(3):187-9. PubMed ID: 2617374
[TBL] [Abstract][Full Text] [Related]
19. Vinblastine and interferon-alpha-2a regimen in the treatment of metastatic renal cell carcinoma.
Palmeri S; Gebbia V; Russo A; Gebbia N; Rausa L
Tumori; 1990 Feb; 76(1):64-5. PubMed ID: 2321276
[TBL] [Abstract][Full Text] [Related]
20. Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma.
Rizzo M; Bartoletti R; Selli C; Sicignano A; Criscuolo D
Eur Urol; 1989; 16(4):271-7. PubMed ID: 2670581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
